These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 770131)
1. Clinical use of immunosuppressive drugs: part I. Gerber NL; Steinberg AD Drugs; 1976; 11(1):14-35. PubMed ID: 770131 [TBL] [Abstract][Full Text] [Related]
2. Azathioprine. Ahmed AR; Moy R Int J Dermatol; 1981 Sep; 20(7):461-7. PubMed ID: 7026466 [No Abstract] [Full Text] [Related]
3. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases. De Jesus A; Talal N Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive therapy in rheumatic disease. Pirofsky B; Bardana EJ Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187 [No Abstract] [Full Text] [Related]
6. [Prospects of the use of cyclosporin A in rheumatic diseases]. Nasonov EL; Shtutman VZ; Nasonova VA Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807 [No Abstract] [Full Text] [Related]
7. [Auto-immune diseases and immunodepressive therapy. II. Current clinical indications]. Delespesse G; Kennes B; Duchateau J Acta Clin Belg; 1974; 29(6):413-23. PubMed ID: 4155218 [No Abstract] [Full Text] [Related]
8. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis. Rosenthal M J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic drugs: their clinical application to the rheumatic diseases. Clements PJ; Davis J Semin Arthritis Rheum; 1986 May; 15(4):231-54. PubMed ID: 2872726 [No Abstract] [Full Text] [Related]
10. Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders. Nashel DJ Med Clin North Am; 1985 Jul; 69(4):817-40. PubMed ID: 3903379 [TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive agents in rheumathology]. Dorfmann H; Dreyfus P Cah Coll Med Hop Paris; 1969 Oct; 10(12):1014-6. PubMed ID: 5308521 [No Abstract] [Full Text] [Related]
12. Medical treatment of connective tissue disease. Ciavaglia SJ; Costello PB; Panara N Ear Nose Throat J; 1987 Nov; 66(11):457-62. PubMed ID: 3443075 [No Abstract] [Full Text] [Related]
13. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis]. Ruszczak Z Hautarzt; 1977 Mar; 28(3):125-31. PubMed ID: 15957 [TBL] [Abstract][Full Text] [Related]
14. [Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases]. Schulze P Z Arztl Fortbild (Jena); 1977 Jun; 71(12):562-4. PubMed ID: 20701 [No Abstract] [Full Text] [Related]
15. The management of collagen diseases. Calin A Ration Drug Ther; 1980 Jan; 14(1):1-5. PubMed ID: 7384531 [No Abstract] [Full Text] [Related]
16. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases]. Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047 [No Abstract] [Full Text] [Related]
17. Methotrexate and its uses in dermatology. Jetton RL Med Times; 1970 Jun; 98(6):83-92. PubMed ID: 4910984 [No Abstract] [Full Text] [Related]
18. [Immunosuppressive treatment of skin diseases. II. Clinical use of immunosuppressive drugs]. Ruszczak Z Przegl Dermatol; 1974; 61(4):529-35. PubMed ID: 4603603 [No Abstract] [Full Text] [Related]
19. The oral-mucosal manifestations of rheumatic diseases. Cummings NA Rheumatology; 1973; 4(0):60-97. PubMed ID: 4600423 [No Abstract] [Full Text] [Related]